logo-loader
LON:GDR

Genedrive PLC

Receive alerts
Market:
LON
Market Cap:
£5.78 m
Price
£0.17
Change
0.00%
52 weeks high
30.00
52 weeks low
15.00

In brief

Genedrive plc is a molecular diagnostics company developing and commercialising a low cost, rapid, versatile, simple to use and robust point of need molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. We are passionate about the opportunity to not only build a sustainable business around molecular diagnostics, but to play an important role in the diagnostic and treatment challenges presented by Global Health issues.

Insight

Research

Genedrive PLC - Interim Results for the six months to December 2017

Genedrive's PLC (LON: GDR) HepC test just entered the commercial phase as partner S...

on 21/3/18
Research

Genedrive -On Track to Launch the First CE-market Decentralised HCV Test

Overall Genedrive PLC (LON: GDR) reported a business and financial update for the six...

on 18/1/18
Research

Genedrive PLC: Overlooked Story Entering the Launch of their HepC Diagnostic Kit

Genedrive (LON:GDR) on track to become a commercial stage, point-of-need diagnostics ...

on 15/11/17
Research

Genedrive - Capital Network: FY 2017 Preliminary results: HepC test launch in sight

KEY INVESTOR MESSAGES Commercial launch of Genedrive® Hepatitis C (HCV) test exp...

on 17/10/17